Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of CVS Health Corp (NYSE: CVS) was $76.75 for the day, up 2.33% from the previous closing price of $75.0. In other words, the price has increased by $2.33 from its previous closing price. On the day, 8.79 million shares were traded. CVS stock price reached its highest trading level at $76.78 during the session, while it also had its lowest trading level at $74.14.
Ratios:
Our analysis of CVS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.48. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.83. In the meantime, Its Debt-to-Equity ratio is 1.12 whereas as Long-Term Debt/Eq ratio is at 1.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $91.
On August 18, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $79.
Robert W. Baird Upgraded its Neutral to Outperform on August 14, 2025, while the target price for the stock was maintained at $82.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 20 ’25 when Finucane Anne A. sold 7,500 shares for $71.02 per share. The transaction valued at 532,650 led to the insider holds 22,156 shares of the business.
Finucane Anne A. bought 7,500 shares of CVS for $532,275 on Aug 20 ’25. On Jun 05 ’25, another insider, SANSONE GUY P, who serves as the Director of the company, bought 1,570 shares for $63.70 each. As a result, the insider paid 100,009 and bolstered with 12,007 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 97428938752 and an Enterprise Value of 168130936832. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 200.55, and their Forward P/E ratio for the next fiscal year is 10.69. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 13.76. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25 while its Price-to-Book (P/B) ratio in mrq is 1.34. Its current Enterprise Value per Revenue stands at 0.429 whereas that against EBITDA is 11.396.
Stock Price History:
The Beta on a monthly basis for CVS is 0.49, which has changed by 0.35648394 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $85.15, while it has fallen to a 52-week low of $43.56. The 50-Day Moving Average of the stock is -2.39%, while the 200-Day Moving Average is calculated to be 10.23%.
Shares Statistics:
CVS traded an average of 7.46M shares per day over the past three months and 6658710 shares per day over the past ten days. A total of 1.27B shares are outstanding, with a floating share count of 1.27B. Insiders hold about 0.16% of the company’s shares, while institutions hold 89.03% stake in the company. Shares short for CVS as of 1763078400 were 19288799 with a Short Ratio of 2.59, compared to 1760486400 on 19523681. Therefore, it implies a Short% of Shares Outstanding of 19288799 and a Short% of Float of 1.54.
Dividends & Splits
With its trailing 12-month dividend rate of 2.66, CVS has a forward annual dividend rate of 2.66. Against a Trailing Annual Dividend Yield of 0.035466667. The stock’s 5-year Average Dividend Yield is 3.16. The current Payout Ratio is 72.76% for CVS, which recently paid a dividend on 2025-10-23 with an ex-dividend date of 2025-10-23. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.
Earnings Estimates
The dynamic stock of CVS Health Corp (CVS) is currently attracting attention from 23.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $2.36, with high estimates of $2.61 and low estimates of $2.1.
Analysts are recommending an EPS of between $6.7 and $6.34 for the fiscal current year, implying an average EPS of $6.59. EPS for the following year is $7.15, with 28.0 analysts recommending between $7.5 and $6.74.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 17 analysts. It ranges from a high estimate of $107.53B to a low estimate of $101.31B. As of. The current estimate, CVS Health Corp’s year-ago sales were $97.71BFor the next quarter, 17 analysts are estimating revenue of $99.85B. There is a high estimate of $101.52B for the next quarter, whereas the lowest estimate is $98.02B.
A total of 21 analysts have provided revenue estimates for CVS’s current fiscal year. The highest revenue estimate was $403.9B, while the lowest revenue estimate was $397.59B, resulting in an average revenue estimate of $399B. In the same quarter a year ago, actual revenue was $372.81BBased on 23 analysts’ estimates, the company’s revenue will be $418.33B in the next fiscal year. The high estimate is $437.63B and the low estimate is $391.95B.
